# In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

No. 20

- 767V (not to be published)

* * * * * * * * * * * * * * * * * * * * * * * * *

GREGORY CARTER

,

Petitioner,

v.

SECRETARY OF HEALTH AND
HUMAN SERVICES,

Respondent.

* * * * * * * * * * * * * * * * * * * * * * * * * *

*

*

*

*

*

*

*

*

*

*

*

*

*

*

*

* Filed: June 1 5 , 2021

Decision by Stipulation; Damages; Tetanus diphtheria acellular pertussis (“Tdap”) Vaccine; Miller Fisher variant of

Guillain

- Barré syndrome (“GBS”)

.

Alison Haskins

, Maglio Christopher & Toale

, Sarasota

, FL

, for Petitioner
James Lopez , U.S. Dep ar t ment of Justice, Washington, DC, for Respondent

DECISION ON JOINT STIPULATION 1

On June 25

, 2020

, Gregory Carter (“ Petitioner ”) filed a petition, seeking compensation under the National Vaccine Injury Compensation Program ( “ the Vaccine Program ” ). 2 Pet., ECF No. 1. Petitioner alleges he suffered from the Miller Fisher variant of Guillain

- Barr é syndrome as
a result of the tetanus diphtheria and acellular pertussis (“Tdap”) vaccination he received on

Fe bruary 27 , 201 8

. See Stipulation ¶ 2, 4, dated June 15 , 202 1 (ECF No. 24 ); see also Petition.

Respondent denies “ that the Tdap vaccine caused petitioner’s alleged GBS or any other

1 Although this Decision has been formally designated “not to be published,” it will nevertheless be posted

on the Court of Federal Claims’ website in accordance with the E

- Government Act of 2002, 44 U.S.C. §
3501 (2012). This means the Decision will be available to anyone with access to the internet . As provided by 42 U.S.C. § 300aa

- 12(d)(4)(B), however, the parties may object to the Decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each p arty has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files
or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the Decision in its present form will be available. Id.

2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L.

No. 99

- 660, 100 Stat. 3755 (codified as amended at 42 U.S.C. §§ 300aa

- 10

– 34 (2012)) (hereinafter “Vaccine Act” or “the Act”). All subsequent references to se ctions of the Vaccine Act shall be to the pertinent subparagraph of 42 U.S.C. § 300aa.injury or condition .” See Stipulation ¶ 6. Nonetheless, both parties, while maintaining their above

stated positions, agreed in a stipulation filed June 15 , 202 1 that the issues before them can be settled and that a decision should be entered awarding Petitioner compensation.

I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation

is reasonable

. I therefore adopt it as my decision in awarding damages on the terms set forth

therein.

The stipulation awards :

a lump sum of $ 10 5 ,000 .00 in th e form of a check payable to [P]etitioner

.

Stipulation ¶ 8. This award represents compensation for all damages that would be available under
42 U.S.C. § 300aa

- 15(a).

I approve a Vaccine Program award in the requested amount set forth above to be made t o
Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the C lerk

of the C ourt is directed to enter judgment herewith. 3

IT IS SO ORDERED.

s/ Katherine E. Oler

Katherine E. Oler Special Master

3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by jointly filing notice renouncing their right to seek review.